Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

1.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.3K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.4K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modeling immune responses to autologous and allogeneic human stem cell-derived islet grafts in vivo.

JCI insight·2026
Same author

Asymmetric attrition and secondary chromosome destabilization after double-strand breaks in human embryonic development.

Nature communications·2026
Same author

A loss of function variant in <i>SLC30A8/ZnT8</i> drives proteomic changes associated with lowered apoptosis in human stem cell-derived islets.

medRxiv : the preprint server for health sciences·2026
Same author

Optical control of Cas9 activity through visible-light cleavable crRNAs.

RSC chemical biology·2026
Same author

Biomaterial-minimalistic photoactivated bioprinting of cell-dense tissues.

Cell·2025
Same author

The Specification and Functional Maturation of Sub-Cerebral Projection Neurons Derived from Human Induced Pluripotent Stem Cells.

Stem cells and development·2025

Related Experiment Video

Updated: May 4, 2026

Nuclear Transfer into Mouse Oocytes
14:17

Nuclear Transfer into Mouse Oocytes

Published on: November 30, 2006

18.0K

Developmental reprogramming after chromosome transfer into mitotic mouse zygotes.

Dieter Egli1, Jacqueline Rosains, Garrett Birkhoff

  • 1The Stowers Medical Institute, Harvard Stem Cell Institute and Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA.

Nature
|June 8, 2007
PubMed
Summary

Researchers found that using mouse zygotes arrested in mitosis, not just oocytes, can successfully create embryonic stem cell lines and cloned animals. This finding suggests human zygotes could also be used for patient-derived stem cells.

More Related Videos

Mouse Oocyte Microinjection, Maturation and Ploidy Assessment
07:03

Mouse Oocyte Microinjection, Maturation and Ploidy Assessment

Published on: July 23, 2011

32.1K
Generation of Mice Derived from Induced Pluripotent Stem Cells
11:56

Generation of Mice Derived from Induced Pluripotent Stem Cells

Published on: November 29, 2012

23.8K

Related Experiment Videos

Last Updated: May 4, 2026

Nuclear Transfer into Mouse Oocytes
14:17

Nuclear Transfer into Mouse Oocytes

Published on: November 30, 2006

18.0K
Mouse Oocyte Microinjection, Maturation and Ploidy Assessment
07:03

Mouse Oocyte Microinjection, Maturation and Ploidy Assessment

Published on: July 23, 2011

32.1K
Generation of Mice Derived from Induced Pluripotent Stem Cells
11:56

Generation of Mice Derived from Induced Pluripotent Stem Cells

Published on: November 29, 2012

23.8K

Area of Science:

  • Reproductive Biology
  • Stem Cell Science
  • Developmental Biology

Background:

  • Somatic cell nuclear transfer (SCNT) typically requires meiotic oocytes for cloning and embryonic stem cell (ESC) production.
  • Previous attempts at SCNT using fertilized interphase zygotes have been unsuccessful.
  • This led to the assumption that unfertilized human oocytes are necessary for patient-specific human ESC generation.

Purpose of the Study:

  • To investigate the potential of using mitotic zygotes for SCNT.
  • To determine if mitotic zygotes can support somatic cell reprogramming and ESC production.
  • To assess the viability of cloned animals derived from SCNT into mitotic zygotes.

Main Methods:

  • Somatic cell nuclear transfer into mouse zygotes temporarily arrested in mitosis.
  • Culture and characterization of resulting embryonic stem cell lines.
  • Assessment of full-term development of cloned animals.

Main Results:

  • Mitotic mouse zygotes, unlike interphase zygotes, successfully supported somatic cell reprogramming.
  • Embryonic stem cell lines were produced from SCNT into mitotic zygotes.
  • Cloned animals were developed to full term from these reprogrammed cells.

Conclusions:

  • Mouse zygotes arrested in mitosis can be used for SCNT, reprogramming, ESC production, and cloning.
  • This challenges the necessity of using only oocytes for SCNT.
  • Human zygotes and potentially embryonic blastomeres may serve as viable alternatives to oocytes for creating patient-derived human ESCs.